MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Sabien Technology Group reports £325k profit for H2 2020

StockMarketWire.com

Sabien Technology Group has recorded a gross profit of £325,000 for the six month period to December 31, 2020, more than double that for the same period in 2019.

Sales revenue for the period reached £412,000, up from £159,000 a year earlier. The company did record a loss before tax of £310,000, compared with a loss of £561,000 for the same period in 2019.

Exceptional costs of £132k were recorded for the six month period, comprising legal and professional fees incurred in relation to the proposed acquisition and reverse takeover of Ptarmigan Health Destinations SA.

In a statement, the chairman of Sabien Technology Group said: 'Whilst it was disappointing to not complete the acquisition and associated reverse takeover of PHD during the period under review, I am convinced that Sabien remains well positioned. Indeed, I look forward to an exciting growth phase over the medium term, both organically and through acquisitions.

'As previously announced, the board was unable to secure the required Swiss and UK regulatory approvals in sufficient time to avoid the cancellation of trading in the company's ordinary shares on the AIM Market. Therefore, the board took the decision to withdraw from the PHD transaction. Following this withdrawal, Cédriane de Boucaud Truell and Marco Nijhof stepped down from the Sabien board to continue PHD's growth plans.'



Story provided by StockMarketWire.com